SCHEMBL2058155

SCHEMBL2058155

CN(C)S(=O)(=O)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10127906 0.82 CA1 (0.33) CA1CA2CA7CA13
SCHEMBL1008667 0.81 CA1 (0.37) CA1CA2CA7CA13
SCHEMBL7920421 0.81 CA2 (0.44) CA1CA2
SCHEMBL28936265 0.79 CA2 (0.48) CA1CA2
SCHEMBL11706292 0.79 CA2 (0.48) CA1CA2
SCHEMBL30444372 0.78 CA1 (0.30) CA1CA2CA7CA13
SCHEMBL25713876 0.78
SCHEMBL27392391 0.76
SCHEMBL7925588 0.75 CA1 (0.30) CA1CA2CA7CA13
SCHEMBL31686017 0.75 CA2 (0.37) CA1CA2CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444695-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES Holdings Pte. Ltd. (SG) 2024-10-16 EP claimed
WO-2024198675-A1 SODIUM-ION BATTERY ELECTROLYTE AND SODIUM-ION BATTERY 杭州菲科技术创新有限公司 2024-10-03 WO claimed
CN-118354997-A Process for producing high purity N, N-dialkyl perfluoroalkyl sulfonamides 麻省固能控股有限公司 2024-07-16 CN claimed
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-20 US claimed
WO-2023105411-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES HOLDINGS PTE. LTD. (SG) 2023-06-15 WO claimed
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-08 US claimed
CN-115621478-A Application of non-aqueous electrolyte containing lithium chlorosulfonyl imide in primary lithium battery 华中科技大学 2023-01-17 CN claimed
WO-2025129749-A1 NEGATIVE ELECTRODE SHEET, BATTERY, PREPARATION METHOD, AND USE 惠州锂威新能源科技有限公司 2025-06-26 WO disclosed
EP-4444695-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES Holdings Pte. Ltd. (SG) 2024-10-16 EP disclosed
WO-2024198675-A1 SODIUM-ION BATTERY ELECTROLYTE AND SODIUM-ION BATTERY 杭州菲科技术创新有限公司 2024-10-03 WO disclosed
CN-118354997-A Process for producing high purity N, N-dialkyl perfluoroalkyl sulfonamides 麻省固能控股有限公司 2024-07-16 CN disclosed
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-20 US disclosed
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-20 US disclosed
US-20110159380-A1 NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2011-06-30 US disclosed
US-20100227226-A1 NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-09-09 US disclosed
US-20100021823-A1 NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-01-28 US disclosed
US-7575833-B2 Nonaqueous electrolyte and lithium secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2009-08-18 US disclosed
US-20070238025-A1 NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2007-10-11 US disclosed
US-7223502-B2 Nonaqueous electrolyte and lithium secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2007-05-29 US disclosed
US-20050118512-A1 Nonaqueous electrolyte and lithium secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide RFC2, AFF2, AFF1 CA1 2305/4885CA2 3249/4885CA7 2465/4885
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide RFC2, AFF2, AFF1 CA1 2305/4885CA2 3249/4885CA7 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.